Logo
ANGIOTENSIN CONVERTING ENZYMES (ACE) INHIBITORS MARKET ANALYSIS
  2. / Market Insights
  3. Angiotensin Converting Enzymes (ACE) Inhibitors Market Analysis
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

ANGIOTENSIN CONVERTING ENZYMES (ACE) INHIBITORS MARKET ANALYSIS

Angiotensin Converting Enzymes (ACE) Inhibitors Market, By Drugs (Benazepril, Perindopril, Trandfolapril, Captopril, Enalapril, Lisinopril, and Others (Ramipril, etc.), ), By Indication (Hypertension, Coronary Artery Disease, Heart Failure, Chronic Kidney Disease, Scleroderma, and Others (Migraine, etc.)), By Route of Administration (Oral and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

  • Published In : Dec 2023
  • Code : CMI2746
  • Pages :160
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Leading Companies

Top companies in Global Angiotensin Converting Enzymes (ACE) Inhibitors Market

  • Novartis AG
  • Pfizer Inc.
  • Merck & Co.
  • AstraZeneca
  • Sanofi
  • Boehringer Ingelheim
  • GlaxoSmithKline
  • Lupin Limited
  • Torrent Pharmaceuticals Ltd.
  • Reddy's Laboratories Ltd.
  • Mylan
  • Other Prominent Players

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

Angiotensin Converting Enzymes (ACE) Inhibitors Market to Surpass US$ 11,831.7 Mn by 2030
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.